Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2000 Feb;49(2):158-67.
doi: 10.1046/j.1365-2125.2000.00132.x.

Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine

K Fattinger  1 , M Roos, P Vergères, C Holenstein, B Kind, U Masche, D N Stocker, S Braunschweig, G A Kullak-Ublick, R L Galeazzi, F Follath, T Gasser, P J Meier
Affiliations
Multicenter Study

Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine

K Fattinger et al. Br J Clin Pharmacol. 2000 Feb.

Abstract

Aims: To explore drug exposure, frequency of adverse drug reactions (ADRs), types of ADRs, predisposing risk factors and ADR-related excess hospital stay in medical inpatients.

Methods: Structured data regarding patient characteristics, 'events' (symptoms, laboratory results), diagnoses (ICD10) and drug therapy were collected using a computer-supported data entry system and an interface for data retrieval from electronic patient records. ADR data were collected by 'event monitoring' to minimize possible bias by the drug monitor. The causality of each event was assessed in relation to disease(s) and drug therapy.

Results: The analysis included 4331 (100%) hospitalizations. The median observation period was 8 days. The median number of different drugs administered per patient and day was 6 and varied between 4 (Q1 ) and 9 (Q3 ) different drugs in 50% of all hospital days. In 41% of all hospitalizations at least one disease-unrelated event could be possibly attributed to drug therapy. Clinically relevant ADRs occurred in 11% of all hospitalizations. In 3.3% of all hospitalizations ADRs were the cause of hospital admission. The incidence of possibly ADR-related deaths was 1.4. Factors predisposing for clinically relevant ADRs were female gender and polypharmacy. ADR-related excess hospital stay accounted for 8. 6% of hospital days.

Conclusions: These data demonstrate the feasibility of the developed 'event monitoring' system for quantitative analysis of ADRs in medical inpatients. With increasing numbers of recorded patients the pharmacoepidemiological database provides a valuable tool to study specific questions regarding drug efficacy and safety in hospitalized patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Event monitoring of ADRs in medical inpatients
Figure 2
Figure 2
Distribution of duration of cohort stay in days for all 4331 hospitalizations recorded. ▄ male, formula image female.
Figure 3
Figure 3
Drug use in medical inpatients: Number of different drugs per patient and day in 4331 hospitalizations in Internal Medicine.
Figure 4
Figure 4
Systems and organs involved in clinically relevant ADRs present during cohort stay (formula image) and involved in ADR-related hospital admissions (formula image) ADRs during cohort stay: Number of hospitalizations with at least one clinically relevant ADR involving the corresponding organ or system. Note that during some hospitalizations more than one clinically relevant ADR occurred and that some ADRs involved several organs or systems. ADR-related hospital admissions: Number of hospitalizations caused by an ADR involving mainly the corresponding organ or systems. Note that some ADRs involved several organs or systems.
See this image and copyright information in PMC

References

    1. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol. 1998;45:301–308. - PMC - PubMed
    1. Einarson TR. Drug-related hospital admissions. Ann Pharmacother. 1993;27:832–840. - PubMed
    1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–1205. - PubMed
    1. Jones JK, Kurata JH, Miwa L. Inpatient Databases. In: Strom BL, editor. Pharmacoepdiemiology. 2. Chichester: John Wiley & Sons; 1994. pp. 257–276.
    1. Lawson DH, Beard K. Intensive Hospital-Besed Cohort Studies. In: Strom BL, editor. Pharmacoepdiemiology. 2. Chichester: John Wiley & Sons; 1994. pp. 157–170.

Publication types

MeSH terms